Login / Signup

Impact of Interleukin-27p28 on T and B Cell Responses during Toxoplasmosis.

Jeongho ParkJonathan H DeLongJames J KnoxChristoph KonradtElia D Tait WojnoChristopher A Hunter
Published in: Infection and immunity (2019)
Interleukin-27 (IL-27) is a heterodimeric cytokine composed of the subunits IL-27p28 and EBi3, and while the IL-27 heterodimer influences T cell activities, there is evidence that IL-27p28 can have EBi3-independent activities; however, their relevance to infection is unclear. Therefore, the studies presented here compared how IL-27p28 transgenics and IL-27p28-/- mice responded to the intracellular parasite Toxoplasma gondii While the loss of IL-27p28 and its overexpression both result in increased susceptibility to T. gondii, the basis for this phenotype reveals distinct roles for IL-27p28. As a component of IL-27, IL-27p28 is critical to limit infection-induced T cell-mediated pathology, whereas the ectopic expression of IL-27p28 reduced the effector T cell population and had a major inhibitory effect on parasite-specific antibody titers and a failure to control parasite replication in the central nervous system. Indeed, transfer of immune serum to infected IL-27p28 transgenics resulted in reduced parasite burden and pathology. Thus, IL-27p28, independent of its role as a component of IL-27, can act as a negative regulator of humoral and cellular responses during toxoplasmosis.
Keyphrases
  • toxoplasma gondii
  • type diabetes
  • poor prognosis
  • cell proliferation
  • risk factors
  • skeletal muscle
  • transcription factor
  • high glucose